Medpace Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
Medpace Holdings, Inc. (MEDP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 6.40 thousand shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-04-26.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2022-04-26
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2022-03-31 was 6.40K shares.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2021-12-31 was 0.00 shares.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2021-09-30 was 1.00K shares.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2017-03-31 was 0.00 shares.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2021 was 12.54K shares.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2020 was 0.00 shares.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2019 was 0.00 shares.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2016 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2022-03-31 | 6.40K shares 10-Q · filed 2022-04-26 | 6.40K shares derived: sum of 2 quarters · filed 2022-04-26 | 7.40K shares derived: sum of 3 quarters · filed 2022-04-26 | |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | 1.00K shares derived: sum of 2 quarters · filed 2022-02-15 | 12.54K shares 10-K · filed 2022-02-15 | |
| 2021-09-30 | 1.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-26 | 12.54K shares 10-Q · filed 2021-10-26 | ||
| 2021-06-30 | 11.54K shares 10-Q · filed 2021-07-27 | |||
| 2020-12-31 | 0.00 shares 10-K · filed 2022-02-15 | |||
| 2019-12-31 | 0.00 shares 10-K · filed 2022-02-15 | |||
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-05-02 | |||
| 2016-12-31 | 0.00 shares 10-K · filed 2017-02-28 | |||
| 2015-12-31 | 0.00 shares 10-K · filed 2017-02-28 | |||
| 2014-12-31 | 0.00 shares 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |